Edwards Lifesciences Q2 2026: $188M California Tax Charge Cuts GAAP EPS to $0.42 While Guidance Rises
Edwards Lifesciences reported net income from continuing operations of $241.4 million for the second quarter of 2026, down 28.1% from $335.9 million a year earlier
- 02
Southern Company (SO) Q2 FY2026: Data Center Surge Drives 23% Adjusted EPS Beat
Southern Company (NYSE: SO) reported Q2 FY2026 adjusted EPS of $1.13, beating consensus by $0.13 (+23% YoY). Net income rose 33% to $1.17B. AI-driven data center load surged 55% YoY, with a landmark 3.2 GW OpenAI deal signed near Savannah. Management raised full-year guidance to "at or near the top" of $4.50–$4.60 and expanded the five-year capital plan to $81B.
- 03
CVS Health (CVS) Q2 FY2026: Net Income Up 2.9x to $2.98B — Stock Falls 6% Despite Guidance Raise
CVS Health posted Q2 2026 revenue of $106.1 billion (+7.3%), operating income of $4.70 billion (+97.5%), and net income attributable to CVS Health of $2.98 bill
LineVest Daily
Get this wrap in your inbox every morning.
One email before the U.S. open — the earnings, filings, and guidance changes that matter, in plain English. Free.
Subscribe free